Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep 1;41(9):e70-e71.
doi: 10.1097/IAE.0000000000003258.

Reply

Affiliations
Comment

Reply

Ji Hun Song et al. Retina. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

None of the authors has any conflicting interests to disclose.

Comment on

References

    1. Gioia M, De Bernardo M, Capasso L, Rosa N. RE: changes in subfoveal choroidal thickness following intravitreal dexamethasone implant therapy for diabetic macular edema. Retina 2021. doi: 10.1097/IAE.0000000000003257. Epub ahead of print. - DOI - PMC - PubMed
    1. Moon KY, Choi SY, Song JH. Changes in subfoveal choroidal thickness after intravitreal dexamethasone implant therapy for diabetic macular edema. Retina 2021;41:1283–1292. - PMC - PubMed
    1. Nourinia R, Ahmadieh H, Nekoei E, et al. . Changes in central choroidal thickness after treatment of diabetic macular edema with intravitreal bevacizumab correlation with central macular thickness and best-corrected visual acuity. Retina 2018;38:970–975. - PubMed
    1. Rewbury R, Want A, Varughese R, Chong V. Subfoveal choroidal thickness in patients with diabetic retinopathy and diabetic macular oedema. Eye (Lond) 2016;30:1568–1572. - PMC - PubMed
    1. Rayess N, Rahimy E, Ying GS, et al. . Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol 2015;159:85–91.e1. - PubMed